Also, ANXA4 has been reported to be involved in tumor spread and anti-cancer drug resistance (Mussunoor and Murray, 2008 ), and was identified as a potential biomarker for gall bladder cancer (Huang et al., 2014). This evidence concerns the gene ANXA4 and cancer.